Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Clare M Isacke Carlo Gambacorti-Passerini Robert Hofstra |
| Publication date | July 30, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |